The ethics of patenting human embryonic stem cells.
Chapman, Audrey R.
Kennedy Institute of Ethics Journal 2009 September; 19(3): 261-288
Just as human embryonic stem cell research has generated controversy about the uses of human embryos for research and therapeutic applications, human embryonic stem cell patents raise fundamental ethical issues. The United States Patent and Trademark Office has granted foundational patents, including a composition of matter (or product) patent to the Wisconsin Alumni Research Foundation (WARF), the University of Wisconsin-Madison's intellectual property office. In contrast, the European Patent Office rejected the same WARF patent application for ethical reasons. This article assesses the appropriateness of these patents placing the discussion in the context of the deontological and consequentialist ethical issues related to human embryonic stem cell patenting. It advocates for a patent system that explicitly takes ethical factors into account and explores options for new types of intellectual property arrangements consistent with ethical concerns.
Permanent LinkFind Full Text at Georgetown University Library.
Full Text from Publisher
Cells; Embryonic Stem Cells; Embryos; Ethics; Intellectual Property; Patents; Property; Research; Stem Cells; Philosophical Ethics; Value / Quality of Life; Social Control of Science and Technology; Genetics, Molecular Biology and Microbiology; Genetic Patents; Stem Cell Research; Research on Embryos and Fetuses;
Showing items related by title, author, creator and subject.